Below are showcased publications produced by NOAHE Members. If you are a NOAHE member and would like to have your publication featured on our website and on social media affiliated with the Network, please contact us at noahe@ihe.ca; Not a NOAHE member? Sign up here!

Please note: The publications listed on this page serve to showcase the work of our individual members only, and do not necessarily represent the views of the Network of Alberta Health Economists (NOAHE), NOAHE Members, and/or NOAHE funders.

Filter your search by clicking filters to the left.

Results for: Kai-Erh Kao Tara Cowling Andrews Tawiah Anderson Chuck Mike Paulden Marie Varughese Christopher McCabe

Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment

One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit

Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting

The Health and Financial Impacts of a Sugary Drink Tax Across Different Income Groups in Canada

The Impact of Hematopoietic Stem Cell Transplantation on Work and Productivity Loss in Patients with Acute Leukemia: Results from a Rapid Review

An Overview of Liquid Biopsy for Screening and Early Detection of Cancer

Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada

Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCT

Hard choices: Reflections from the tomb of the unknown patient

Early Initiation of Tumor Necrosis Factor Antagonist-Based Therapy for Patients With Crohn's Disease Reduces Costs Compared With Late Initiation

Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Multiple Myeloma Treatment Landscape from 2011-2017: Results from the Population-Based "Identifying Outcomes in Real-World Multiple Myeloma"

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer

Early mortality following diagnosis of multiple myeloma from 2011 to 2016 in Alberta, Canada: Initial results from the population-based Identifying Outcomes in Real-World Multiple Myeloma (INFORMM) st

Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis.

Cell-Free DNA–Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis

Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA-Prelim Trial

A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models

Show Drugs Work Before Selling Them

Determinants of Change in the Cost-effectiveness Threshold

The State of Health Economics in Alberta: A Review of Need, Capacity, and Action